FLUPHENAZINE Side Effects

7019661-6 | Oculogyric Crisis
on Sep 28, 2010 Female patient from UNITED STATES , 42 years of age, weighting 120.0 lb, was treated with Fluphenazine (View Usage). Patient experienced the following unwanted or unexpected effects: oculogyric crisis. Fluphenazine dosage: 62.5 Mg Every 2 Weeks Im.

7014174-X | Atrial Fibrillation, Renal Failure Acute
Patient was taking Fluphenazine (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), renal failure acute on Sep 24, 2010 from UNITED STATES Additional patient health information: Female patient , 75 years of age, . Fluphenazine dosage: 1 Mg 1 Mg Qam, 2 Mg Qpm Po. Patient was hospitalized.

6958418-9 | Abdominal Distension, Chromaturia, Urine Analysis Abnormal
Adverse event was reported on Aug 30, 2010 by a Female patient taking Fluphenazine (View Usage) (Dosage: 3 Tabs. 2 X Day) was diagnosed with mood swings, nervousness and. Location: UNITED STATES , weighting 160.0 lb, After Fluphenazine was administered, patient had the following side effects: abdominal distension, chromaturia, urine analysis abnormal.

6765063-7 | Dystonia, Neuroleptic Malignant Syndrome
on Jun 09, 2010 Male patient from UNITED STATES , 60 years of age, weighting 240.1 lb, was diagnosed with schizophrenia, paranoid type and was treated with Fluphenazine (View Usage). Patient experienced the following unwanted or unexpected effects: dystonia (What is dystonia?), neuroleptic malignant syndrome. Fluphenazine dosage: 50 Mg Other Im. Patient was hospitalized.


6671158-9 | Dysarthria, Dystonia, Muscular Weakness
on Apr 06, 2010 Male patient from UNITED STATES , 44 years of age, was diagnosed with schizophrenia and was treated with Fluphenazine (View Usage). Patient had the following side effects: dysarthria, dystonia (What is dystonia?), muscular weakness. Fluphenazine dosage: 5mg Bid Po. Patient was hospitalized.

6655582-6 | Gait Disturbance, Parkinsonism
Patient was taking Fluphenazine (View Usage). After Fluphenazine was administered, patient had the following side effects: gait disturbance, parkinsonism on Mar 26, 2010 from UNITED STATES Additional patient health information: Male patient , 64 years of age, was diagnosed with schizoaffective disorder and. Fluphenazine dosage: 37.5 Mg Im. Patient was hospitalized and became disabled.

6644000-X | Asthenia, Balance Disorder, Fatigue, Parkinson's Disease, Walking Aid User
Adverse event was reported on Mar 19, 2010 by a Female patient taking Fluphenazine (View Usage) (Dosage: 2.5 Mg 1 Tab At Bedtime) was diagnosed with bipolar disorder (What is bipolar disorder?) and. Location: UNITED STATES , weighting 195.0 lb, Patient experienced the following unwanted or unexpected effects: asthenia, balance disorder, fatigue, parkinson's disease (What is parkinson's disease?), walking aid user. Patient was hospitalized and became disabled.

6569301-5 | Infection, Neutrophil Count Decreased
on Feb 01, 2010 Male patient from UNITED STATES , 53 years of age, weighting 165.3 lb, was diagnosed with schizophrenia and was treated with Fluphenazine (View Usage). Patient had the following side effects: infection (What is infection?), neutrophil count decreased. Fluphenazine dosage: 5mg Bid Po. During the same period patient was treated with FLUPHENAZINE DEC 25MG/ML (25mg Q2 Weeks Im) (View Fluphenazine Dec 25mg/ml Review and Fluphenazine Dec 25mg/ml Label ), COGENTIN (View Cogentin Review and Cogentin Label ), APAP PRN (View Apap Prn Review and Apap Prn Label ), ANTACID/ANTIGAS PRN (View Antacid/antigas Prn Review and Antacid/antigas Prn Label ), TUBERSOL (View Tubersol Review and Tubersol Label ).

6566001-2 | Neutrophil Count Decreased
on Jan 29, 2010 Male patient from UNITED STATES , 53 years of age, weighting 165.3 lb, was diagnosed with schizophrenia and was treated with Fluphenazine (View Usage). After Fluphenazine was administered, patient had the following side effects: neutrophil count decreased. Fluphenazine dosage: 5mg Bid Po.

6500232-2 | Electrocardiogram Qt Prolonged
Patient was taking Fluphenazine (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram qt prolonged on Dec 15, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 222.7 lb, was diagnosed with schizophrenia and. Fluphenazine dosage: 17.5mg Q 3 Weeks Im.

6466344-7 | Bruxism, Muscle Twitching
Adverse event was reported on Dec 01, 2009 by a Female patient taking Fluphenazine (View Usage) (Dosage: .3cc Twice A Month Im) was diagnosed with nervous system disorder and. Location: UNITED STATES , 62 years of age, weighting 198.0 lb, Patient had the following side effects: bruxism, muscle twitching.

6307860-8 | Aggression, Extrapyramidal Disorder, Hallucination, Heart Rate Increased, Hyperhidrosis, Pyrexia, Renal Disorder, Rhabdomyolysis
on Aug 12, 2009 Male patient from UNITED STATES , 48 years of age, weighting 160.0 lb, was diagnosed with schizophrenia and was treated with Fluphenazine (View Usage). After Fluphenazine was administered, patient had the following side effects: aggression, extrapyramidal disorder, hallucination, heart rate increased, hyperhidrosis, pyrexia, renal disorder, rhabdomyolysis. Fluphenazine dosage: 75mg One Im One Dose. Patient was hospitalized.

6239689-3 | Extrapyramidal Disorder, Lethargy
on Jun 10, 2009 Male patient from AUSTRALIA , 31 years of age, was treated with Fluphenazine (View Usage). Patient experienced the following unwanted or unexpected effects: extrapyramidal disorder, lethargy. Fluphenazine dosage: 50 Mg On Alternate Days (days 1, 3 And 5; Total Of 150 Mg), Intramuscular. During the same period patient was treated with DECA DURABOLIN (View Deca-durabolin Review and Deca-durabolin Label ). Patient was hospitalized.

6239688-1 | Akathisia, Blood Creatine Phosphokinase Increased, Dystonia, Extrapyramidal Disorder
Patient was taking Fluphenazine (View Usage). Patient had the following side effects: akathisia, blood creatine phosphokinase increased, dystonia (What is dystonia?), extrapyramidal disorder on Jun 10, 2009 from AUSTRALIA Additional patient health information: Male patient , 31 years of age, . Fluphenazine dosage: 50 Mg (2 Depots, Intramuscular. Patient was hospitalized.

6153411-0 | Oromandibular Dystonia
Adverse event was reported on Apr 09, 2009 by a Male patient taking Fluphenazine (View Usage) (Dosage: 5 Mg Once Im) was diagnosed with psychotic disorder (What is psychotic disorder?) and. Location: UNITED STATES , 41 years of age, weighting 180.8 lb, After Fluphenazine was administered, patient had the following side effects: oromandibular dystonia.

6043458-7 | Cardiac Arrest, Completed Suicide, Respiratory Arrest
on Jan 06, 2009 Male patient from UNITED STATES , 49 years of age, was treated with Fluphenazine (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), completed suicide, respiratory arrest. Fluphenazine dosage: (df Oral).

5951078-5 | Drooling, Dysarthria, Dysphagia, Hypophagia, Insomnia, Parkinsonism, Restlessness, Speech Disorder, Tardive Dyskinesia
on Nov 11, 2008 Male patient from UNITED STATES , 45 years of age, was diagnosed with schizophrenia and was treated with Fluphenazine (View Usage). Patient had the following side effects: drooling, dysarthria, dysphagia, hypophagia, insomnia, parkinsonism, restlessness, speech disorder, tardive dyskinesia. Fluphenazine dosage: 50 Mg Other Im. Patient was hospitalized.

5841130-7 | Neuroleptic Malignant Syndrome, Renal Failure Acute, Renal Tubular Necrosis
Patient was taking Fluphenazine (View Usage). After Fluphenazine was administered, patient had the following side effects: neuroleptic malignant syndrome, renal failure acute, renal tubular necrosis on Aug 11, 2008 from UNITED STATES Additional patient health information: Male patient , 54 years of age, weighting 194.0 lb, was diagnosed with schizoaffective disorder, surgery (What is surgery?) and. Fluphenazine dosage: 125 Mg Other Im. During the same period patient was treated with CLOZAPINE (400 Mg Hs Po) (View Clozapine Review and Clozapine Label ). Patient was hospitalized.

5822880-5 | Hyponatraemia
Adverse event was reported on Jul 24, 2008 by a Female patient taking Fluphenazine (View Usage) (Dosage: ) . Location: UNITED STATES , 54 years of age, Patient experienced the following unwanted or unexpected effects: hyponatraemia. Patient was hospitalized.

5813353-4 | Convulsion, Hyponatraemia
on Jul 16, 2008 Male patient from UNITED STATES , 33 years of age, was treated with Fluphenazine (View Usage). Patient had the following side effects: convulsion, hyponatraemia. Fluphenazine dosage: See Above. Patient was hospitalized.

5679996-6 | Catatonia, Dyskinesia
on Mar 25, 2008 Male patient from UNITED STATES , 62 years of age, weighting 165.3 lb, was diagnosed with bipolar disorder (What is bipolar disorder?), mania and was treated with Fluphenazine (View Usage). After Fluphenazine was administered, patient had the following side effects: catatonia, dyskinesia. Fluphenazine dosage: 25mg Q2weeks Im. Patient was hospitalized.

5605358-3 | Poisoning
Patient was taking Fluphenazine (View Usage). Patient experienced the following unwanted or unexpected effects: poisoning (What is poisoning?) on Jan 07, 2008 from UNITED STATES Additional patient health information: Female patient , 41 years of age, . Fluphenazine dosage: Df Parenteral.

5570371-1 | Extrapyramidal Disorder, Psychotic Disorder, Refusal Of Treatment By Patient
Adverse event was reported on Dec 19, 2007 by a Male patient taking Fluphenazine (View Usage) (Dosage: 25mg Im Q 2 Weeks) . Location: UNITED STATES , 49 years of age, weighting 200.0 lb, Patient had the following side effects: extrapyramidal disorder, psychotic disorder (What is psychotic disorder?), refusal of treatment by patient. During the same period patient was treated with ZOCOR (View Zocor Review and Zocor Label ), NORVASC (View Norvasc Review and Norvasc Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), ABILIFY (View Abilify Review and Abilify Label ), PERPHENAZINE (View Perphenazine Review and Perphenazine Label ), CALCIUM POLYCARBOPHIL (View Calcium Polycarbophil Review and Calcium Polycarbophil Label ), DOCUSATE (View Docusate Review and Docusate Label ).

5567981-4 | Blood Pressure Decreased, Tachycardia
on Dec 18, 2007 Male patient from UNITED STATES , 22 years of age, weighting 185.0 lb, was treated with Fluphenazine (View Usage). After Fluphenazine was administered, patient had the following side effects: blood pressure decreased, tachycardia. Fluphenazine dosage: 125mg Im. During the same period patient was treated with MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), BENZTROPINE (View Benztropine Review and Benztropine Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ).

5566662-0 | Blood Creatine Phosphokinase Increased
on Dec 18, 2007 Male patient from UNITED STATES , 40 years of age, weighting 200.0 lb, was treated with Fluphenazine (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased. Fluphenazine dosage: 60mg Po. During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), BUSPIRONE HCL (View Buspirone Hcl Review and Buspirone Hcl Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), TOPAMAX (View Topamax Review and Topamax Label ).

5566621-8 | Blood Creatine Phosphokinase Increased
Patient was taking Fluphenazine (View Usage). Patient had the following side effects: blood creatine phosphokinase increased on Dec 18, 2007 from UNITED STATES Additional patient health information: Male patient , 48 years of age, weighting 198.0 lb, . Fluphenazine dosage: 5mg Po. During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

5485330-7 | Extrapyramidal Disorder, Parkinsonism
Adverse event was reported on Oct 10, 2007 by a Male patient taking Fluphenazine (View Usage) (Dosage: 37.5mg Other Im) . Location: UNITED STATES , 72 years of age, After Fluphenazine was administered, patient had the following side effects: extrapyramidal disorder, parkinsonism.

5420882-4 | Paranoia, Refusal Of Treatment By Patient, Trismus
on Aug 17, 2007 Male patient from UNITED STATES , weighting 173.3 lb, was diagnosed with schizophrenia and was treated with Fluphenazine (View Usage). Patient experienced the following unwanted or unexpected effects: paranoia, refusal of treatment by patient, trismus. Fluphenazine dosage: 15 Mg/day.

5420285-2 | Base Excess Decreased, Blood Bicarbonate Decreased, Blood Chloride Decreased, Bradypnoea, Brain Oedema, Cardiac Arrest, Coma
on Jul 02, 2007 Male patient from CROATIA (local name: Hrvatska) , 44 years of age, was diagnosed with mental disorder and was treated with Fluphenazine (View Usage). Patient had the following side effects: base excess decreased, blood bicarbonate decreased, blood chloride decreased, bradypnoea, brain oedema, cardiac arrest (What is cardiac arrest?), coma. Fluphenazine dosage: 25 Mg,2 In 1 M, Intramuscular; 40 Mg (40 Mg, 1 In 1 D), Oral. During the same period patient was treated with HALOPERIDOL (12 Mg (12 Mg, 1 In 1 D), Oral) (View Haloperidol Review and Haloperidol Label ), OLANZAPINE (30 Mg (30 Mg, 1 In 1 D) Oral) (View Olanzapine Review and Olanzapine Label ), PAROXETINE (20 Mg (20 Mg, 1 In 1 D), Oral) (View Paroxetine Review and Paroxetine Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), BIPERIDEN HYDROCHLORIDE TAB (View Biperiden Hydrochloride Tab Review and Biperiden Hydrochloride Tab Label ), BROMAZEPAM (BROMAZEPAM) (View Bromazepam (bromazepam) Review and Bromazepam (bromazepam) Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

5262357-1 | Blood Creatine Phosphokinase Increased, Blood Pressure Increased, Heart Rate Increased, Muscle Rigidity
Patient was taking Fluphenazine (View Usage). After Fluphenazine was administered, patient had the following side effects: blood creatine phosphokinase increased, blood pressure increased, heart rate increased, muscle rigidity on Mar 08, 2007 from UNITED STATES Additional patient health information: Male patient , 30 years of age, weighting 279.0 lb, . Fluphenazine dosage: 5mg Bid Po.

5154708-3 | Dyskinesia, Dystonia, Oropharyngeal Spasm
Adverse event was reported on Nov 16, 2006 by a Male patient taking Fluphenazine (View Usage) (Dosage: Bid Po) was diagnosed with psychotic disorder (What is psychotic disorder?) and. Location: UNITED STATES , 45 years of age, weighting 147.0 lb, Patient experienced the following unwanted or unexpected effects: dyskinesia, dystonia (What is dystonia?), oropharyngeal spasm. During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ).

5029584-X | Depression, Initial Insomnia
on Jun 09, 2006 Male patient from GERMANY , 51 years of age, was treated with Fluphenazine (View Usage). Patient had the following side effects: depression (What is depression?), initial insomnia. Fluphenazine dosage: . During the same period patient was treated with CLOZAPINE (50 Mg, Qhs) (View Clozapine Review and Clozapine Label ).

4830029-0 | Dizziness, Eye Injury, Fall, Foot Fracture, Orthostatic Hypotension, Syncope
on Nov 15, 2005 Male patient from UNITED STATES , 56 years of age, weighting 206.0 lb, was diagnosed with schizophrenia and was treated with Fluphenazine (View Usage). After Fluphenazine was administered, patient had the following side effects: dizziness (What is dizziness?), eye injury, fall (What is fall?), foot fracture, orthostatic hypotension, syncope. Fluphenazine dosage: 5mg Am, 10mg Pm Po. During the same period patient was treated with SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

4697999-5 | Imprisonment, Psychotic Disorder, Sedation
Patient was taking Fluphenazine (View Usage). Patient experienced the following unwanted or unexpected effects: imprisonment, psychotic disorder (What is psychotic disorder?), sedation on Jan 19, 2005 from Additional patient health information: Male patient , 52 years of age, weighting 220.0 lb, was diagnosed with schizophrenia, paranoid type and. Fluphenazine dosage: 25 Mg Im Q Week. During the same period patient was treated with PROLIXIN DECANOATE (View Prolixin Decanoate Review and Prolixin Decanoate Label ), DEPAKOTE (View Depakote Review and Depakote Label ), TRAZODONE (View Trazodone Review and Trazodone Label ). Patient was hospitalized.

4646017-3 | Arrhythmia, Circulatory Collapse
Adverse event was reported on Apr 22, 2005 by a Female patient taking Fluphenazine (View Usage) (Dosage: ) was diagnosed with psychotic disorder (What is psychotic disorder?) and. Location: , 43 years of age, weighting 213.0 lb, Patient had the following side effects: arrhythmia (What is arrhythmia?), circulatory collapse.

4623158-8 | Hyperthyroidism
on Mar 11, 2005 Male patient from , 56 years of age, was treated with Fluphenazine (View Usage). After Fluphenazine was administered, patient had the following side effects: hyperthyroidism. Fluphenazine dosage: .

4621580-7 | Thrombocytopenia
on Apr 26, 2004 Male patient from , 24 years of age, was diagnosed with schizophrenia and was treated with Fluphenazine (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia. Fluphenazine dosage: 6 Mg. During the same period patient was treated with CLOZAPINE (37.5 Mg) (View Clozapine Review and Clozapine Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ).

4621578-9 | Confusional State, Sedation, Urinary Tract Infection
Patient was taking Fluphenazine (View Usage). Patient had the following side effects: confusional state, sedation, urinary tract infection (What is urinary tract infection?) on Jun 18, 2003 from Additional patient health information: Female patient , 66 years of age, was diagnosed with schizophrenia and. Fluphenazine dosage: 25 Mg Freq Unk, Im. During the same period patient was treated with RISPERIDONE (1 Mg Mane/2 Mg Nocte, Po) (View Risperidone Review and Risperidone Label ), LORAZEPAM (1 Mg Nocte, Po) (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

4621560-1 | Blood Iron Decreased, Blood Pressure Fluctuation, Chills, Coma, Confusional State, Disorientation, Grand Mal Convulsion, Hypokalaemia, Neuroleptic Malignant Syndrome
Adverse event was reported on Apr 26, 2004 by a Female patient taking Fluphenazine (View Usage) (Dosage: Inj) was diagnosed with mental disorder and. Location: , 33 years of age, After Fluphenazine was administered, patient had the following side effects: blood iron decreased, blood pressure fluctuation, chills, coma, confusional state, disorientation, grand mal convulsion, hypokalaemia, neuroleptic malignant syndrome. During the same period patient was treated with OLANZAPINE (10 Mg) (View Olanzapine Review and Olanzapine Label ). Patient was hospitalized.

4621558-3 | Maculopathy, Ocular Toxicity, Visual Acuity Reduced
on Aug 31, 2004 Female patient from , 46 years of age, was diagnosed with schizophrenia and was treated with Fluphenazine (View Usage). Patient experienced the following unwanted or unexpected effects: maculopathy, ocular toxicity, visual acuity reduced. Fluphenazine dosage: 25 Mg Fortnightly.

4616351-1 | Blood Amylase Increased, Cellulitis, Fluid Intake Reduced, Lipase Increased, Neuroleptic Malignant Syndrome, Oral Intake Reduced, Pneumonia Aspiration, Respiratory Distress
on Apr 26, 2004 Male patient from , 57 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Fluphenazine (View Usage). Patient had the following side effects: blood amylase increased, cellulitis (What is cellulitis?), fluid intake reduced, lipase increased, neuroleptic malignant syndrome, oral intake reduced, pneumonia aspiration, respiratory distress. Fluphenazine dosage: 20 Mg Daily. During the same period patient was treated with DIVALPROEX SODIUM (2500 Mg Daily) (View Divalproex Sodium Review and Divalproex Sodium Label ), OLANZAPINE (30 Mg Daily) (View Olanzapine Review and Olanzapine Label ), BENZTROPINE MESYLATE (2 Mg Daily) (View Benztropine Mesylate Review and Benztropine Mesylate Label ). Patient was hospitalized.

4608378-0 | Cogwheel Rigidity, Movement Disorder, Musculoskeletal Stiffness
Patient was taking Fluphenazine (View Usage). After Fluphenazine was administered, patient had the following side effects: cogwheel rigidity, movement disorder (What is movement disorder?), musculoskeletal stiffness on Mar 11, 2005 from Additional patient health information: Female patient , weighting 108.0 lb, was diagnosed with schizoaffective disorder and. Fluphenazine dosage: 5 Mg Po Bid.

4589184-2 | Musculoskeletal Stiffness
Adverse event was reported on Feb 15, 2005 by a Male patient taking Fluphenazine (View Usage) (Dosage: 25mg Q2w Intramuscular) . Location: , weighting 128.0 lb, Patient experienced the following unwanted or unexpected effects: musculoskeletal stiffness.